Study guide
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature
Key Takeaways Explain This Topic AI
Pulse oximetry relies on the Beer-Lambert law and dual optical wavelengths (660 nm red for deoxyhemoglobin, 940 nm infrared for oxyhemoglobin) to calculate the absorption ratio R; an R ratio of 1.0 corresponds to an SpO₂ of 85%, while R = 0.4 corresponds to 100%.
Carboxyhemoglobin absorbs 660 nm light identically to oxyhemoglobin, producing falsely elevated SpO₂ readings; Methemoglobin absorbs equally at 660 nm and 940 nm (R = 1.0), locking the displayed SpO₂ at ~85% regardless of true arterial oxygenation.
Time capnography encompasses four distinct phases: Phase I (anatomical dead space), Phase II (mixed dead space and alveolar gas), Phase III (alveolar plateau), and Phase 0 (inspiratory downstroke); ETCO₂ is measured at the end of Phase III (Point D).
An elevated alpha angle (>110°) indicates expiratory airflow obstruction (bronchospastic 'shark fin'), while an elevated beta angle (>90°) or baseline elevation indicates rebreathing of CO₂ or incompetent expiratory unidirectional valves.
Perioperative hypothermia progresses through three phases: internal redistribution (1.0-1.5°C drop in hour 1), linear heat loss, and thermal plateau; post-anesthetic shivering increases metabolic oxygen consumption by up to 400%, precipitating myocardial ischemia and metabolic acidosis.
Last updated: August 2026
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature
Noninvasive physiological monitoring constitutes the primary line of defense in modern anesthesia practice. A thorough understanding of the optical physics of pulse oximetry, infrared gas analysis in capnography, and thermoregulatory physiology enables the CRNA to rapidly distinguish between true patient emergencies, equipment malfunctions, and physiological artifacts.
1. Pulse Oximetry Physics & Spectrophotometry
Pulse oximetry provides continuous, noninvasive estimation of arterial hemoglobin oxygen saturation ( S p O 2 SpO_2 Sp O 2 ) and peripheral pulse rate by combining two physical principles: spectrophotometry (light absorption by hemoglobin species) and optical plethysmography (detection of pulsatile vascular volume changes). +-------------------------------------------------------------------------+
- | PULSE OXIMETRY DUAL-WAVELENGTH OPTICS |
- +------------------------------------+------------------------------------+
- | Red Light (660 nm) | Infrared Light (940 nm) |
- +------------------------------------+------------------------------------+
- | • Preferentially absorbed by | • Preferentially absorbed by |
- | Deoxygenated Hemoglobin (DeoxyHb)| Oxygenated Hemoglobin (OxyHb) |
- | • DeoxyHb extinction is ~10x | • OxyHb extinction is higher at |
- | higher than OxyHb at 660 nm | 940 nm than DeoxyHb |
- +------------------------------------+------------------------------------+
- The Beer-Lambert Law
Pulse oximeter microprocessors apply the combined Beer-Lambert Law to quantify solute concentration based on light transmission: I = I 0 ⋅ e − α ⋅ C ⋅ d I = I_0 \cdot e^{-\alpha \cdot C \cdot d} I = I 0 ⋅ e − α ⋅ C ⋅ d
Where:
- I = I = I = Transmitted light intensity
- I 0 = I_0 = I 0 = Incident light intensity
α = \alpha = α = Extinction coefficient (molar absorptivity of the specific hemoglobin species at a chosen wavelength)
- C = C = C = Hemoglobin concentration
- d = d = d = Optical path length (tissue and vascular bed thickness)
- Optical Plethysmography & The R Value
The pulse oximeter probe houses two light-emitting diodes (LEDs)—emitting at 660 nm 660 \text{ nm} 660 nm (visible red) and 940 nm 940 \text{ nm} 940 nm (near-infrared)—and a single silicon photodiode receiver. The sensor samples light thousands of times per second and divides the transmitted light into two distinct components:
Pulsatile (AC) Component: Light absorbed by expanding arterial blood during ventricular systole.
Non-Pulsatile (DC) Component: Baseline light absorbed by non-pulsatile venous blood, capillary blood, muscle, bone, and connective tissue.
By dividing the AC signal by the DC signal at both wavelengths, the microprocessor eliminates background tissue absorption and calculates the Red-to-Infrared Absorption Ratio ( R R R ) : R = ( A C 660 D C 660 ) ( A C 940 D C 940 ) R = \frac{\left(\frac{AC_{660}}{DC_{660}}\right)}{\left(\frac{AC_{940}}{DC_{940}}\right)} R = ( D C 940 A C 940 ) ( D C 660 A C 660 ) +-------------------------------------------------------------------------+
- | R VALUE TO SpO₂ CALIBRATION RELATIONSHIP |
- +-------------------+-----------------------------------------------------+
- | R Ratio Value | Calibrated Saturation Displayed |
- +-------------------+-----------------------------------------------------+
- | R = 0.4 | SpO₂ = 100% (Infrared absorption dominates) |
- | R = 1.0 | SpO₂ = 85% (Red and Infrared absorption are equal) |
- | R = 2.0 | SpO₂ = 0% (Red absorption dominates) |
- +-------------------+-----------------------------------------------------+
- Isobestic Points
An isobestic point is a specific optical wavelength where two distinct chemical substances possess identical molar extinction coefficients (absorb light equally regardless of oxygenation state).
Primary Isobestic Point for Hemoglobin: 805 nm 805 \text{ nm} 805 nm (also 590 nm 590 \text{ nm} 590 nm ). At 805 nm 805 \text{ nm} 805 nm , deoxygenated hemoglobin and oxyhemoglobin absorb light identically.
Significance in Co-Oximetry: Light absorption at an isobestic wavelength depends strictly on total hemoglobin concentration, independent of oxygen saturation.
2. Dyshemoglobinemias, Intravenous Dyes & Measurement Artifacts
Standard clinical pulse oximeters assume only two circulating hemoglobin species: functional oxyhemoglobin ( H b O 2 HbO_2 H b O 2 ) and deoxygenated hemoglobin ( H b Hb H b ). When abnormal dyshemoglobins or optical dyes are present, standard dual-wavelength pulse oximetry becomes inaccurate, requiring multi-wavelength fractional co-oximetry for accurate measurement. +-------------------------------------------------------------------------+
- | DYSHEMOGLOBIN & DYE INTERFERENCE SUMMARY |
- +------------------+----------------------------------+-------------------+
- | Interfering Agent| Optical Mechanism | SpO₂ Effect |
- +------------------+----------------------------------+-------------------+
- | Carboxyhemoglobin| Absorbs 660 nm identically to | Falsely elevated |
- | (CO-Hb) | OxyHb; negligible at 940 nm | (reads ~100%) |
- | Methemoglobin | High, equal absorption at both | Fixed at ~85% |
- | (Met-Hb) | 660 nm and 940 nm (R = 1.0) | (over/under reads)|
- | Methylene Blue | Massive absorption at 660 nm | Precipitous drop |
- | Dye | mimics pure DeoxyHb | to ~65% for 1-2 m |
- | Indigo Carmine | Mild optical absorption at 660 nm| Slight false drop |
- | Indocyanine Green| Moderate absorption at 800-900 nm| Slight false drop |
- +------------------+----------------------------------+-------------------+
- Carboxyhemoglobin (CO-Hb)
Etiology: Smoke inhalation, structure fires, carbon monoxide poisoning, tobacco smoking, or volatile anesthetic degradation in desiccated carbon dioxide absorbents (most pronounced with desflurane).
Optical Trap: CO-Hb has an extinction coefficient at 660 nm 660 \text{ nm} 660 nm virtually identical to oxyhemoglobin ( H b O 2 HbO_2 H b O 2 ). Standard pulse oximeters interpret CO-Hb as H b O 2 HbO_2 H b O 2 .
Clinical Impact: A patient with 40 % 40\% 40% CO-Hb and 60 % 60\% 60% true oxyhemoglobin will display an SpO₂ of 98 − 100 % 98 - 100\% 98 − 100% , masking severe, life-threatening arterial hypoxemia and cellular asphyxiation. Fractional saturation via co-oximetry is mandatory.
Methemoglobin (Met-Hb)
Pathophysiology: Iron in heme is oxidized from the ferrous state ( F e 2 + Fe^{2+} F e 2 + ) to the ferric state ( F e 3 + Fe^{3+} F e 3 + ), which cannot bind oxygen. It also creates a severe leftward shift of remaining normal heme groups.
Etiologies: Topical local anesthetics (benzocaine sprays like Hurricaine, prilocaine/EMLA), intravenous lidocaine, sodium nitroprusside infusions, dapsone, sulfonamides, nitric oxide, and aniline dyes.
Optical Trap: Methemoglobin absorbs heavily and equally at both 660 nm 660 \text{ nm} 660 nm and 940 nm 940 \text{ nm} 940 nm , driving the R R R ratio toward 1.0 1.0 1.0 . As a result, the displayed SpO₂ locks at ≈ 85 % \approx 85\% ≈ 85% regardless of the patient's true arterial P a O 2 PaO_2 P a O 2 .
If true S a O 2 SaO_2 S a O 2 is 99 % 99\% 99% , the monitor reads falsely low ( 85 % 85\% 85% ).
If true S a O 2 SaO_2 S a O 2 is 50 % 50\% 50% , the monitor reads falsely high ( 85 % 85\% 85% ).
Treatment: Methylene Blue 1 − 2 mg/kg 1 - 2 \text{ mg/kg} 1 − 2 mg/kg IV administered over 5 minutes. Methylene blue is reduced by erythrocyte NADPH-methemoglobin reductase into leukomethylene blue, which acts as an electron donor to reduce F e 3 + Fe^{3+} F e 3 + back to F e 2 + Fe^{2+} F e 2 + .
Critical Caution: In patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency , methylene blue is ineffective (lacks sufficient NADPH) and may induce severe, life-threatening acute hemolytic anemia; ascorbic acid (vitamin C) is used alternatively.
Intravenous Dyes & Optical Artifacts
Methylene Blue: Absorbs strongly at 660 nm 660 \text{ nm} 660 nm , driving the red-to-infrared ratio up and causing a transient, steep plunge in displayed SpO₂ (often down to 60 − 65 % 60 - 65\% 60 − 65% ) lasting 1 − 2 minutes 1 - 2 \text{ minutes} 1 − 2 minutes before returning to baseline.
Nail Polish & Ambient Light: Black, blue, and dark green nail polishes absorb 660 nm 660 \text{ nm} 660 nm light and cause falsely low SpO₂ readings (red nail polish has minimal effect). Ambient fluorescent lights and infrared heating lamps can scatter optical sensors; covering the probe with an opaque shield resolves optical ambient interference.
Low Perfusion States: Severe hypothermia, peripheral vasoconstriction, cardiopulmonary bypass, and profound shock attenuate the pulsatile AC signal, resulting in loss of tracking or inaccurate saturation display.
3. Capnography Fundamentals & Normal Waveform Morphology
Capnography is the continuous measurement and graphic display of carbon dioxide tension in respiratory gases over time. It is the gold standard monitor for verifying endotracheal tube placement, detecting circuit disconnections, and assessing the adequacy of pulmonary ventilation and perfusion. [NORMAL TIME CAPNOGRAM (PHASES I - 0)]
- CO₂ (mmHg)
- 50 |
- | Phase III (Alveolar Plateau)
- 40 | /-----------------------D (ETCO₂)
- | / (Alpha Angle: 100-110°)
- 30 | / |
- | Phase II / | Phase 0
- 20 | (Expiratory/ | (Inspiratory
- | Upstroke)/ | Downstroke)
- 10 | / |
- | Phase I / |
- 0 +-------------+-------------------------------+-----
- Inspiratory Baseline Time (sec)
- The Four Phases of the Time Capnogram
Phase Functional Designation Physiological Gas Composition & Dynamics
Phase I Inspiratory Baseline Exhalation of carbon dioxide-free anatomical dead space gas ( V D V_D V D ) from conducting airways (trachea, bronchi). Normally reads 0 mmHg 0 \text{ mmHg} 0 mmHg .
Phase II Expiratory Upstroke Rapid transition representing the mixture of anatomical dead space gas and early alveolar gas ( V A V_A V A ) arriving at the airway sensor.
Phase III Alveolar Plateau Sustained exhalation of pure alveolar gas from functional gas-exchanging alveoli. Slopes gently upward due to ongoing cellular C O 2 CO_2 C O 2 diffusion and V / Q V/Q V / Q variation across lung units.
Point D End-Tidal C O 2 CO_2 C O 2 ( P E T C O 2 P_{ET}CO_2 P ET C O 2 ) The terminal point of Phase III representing the peak C O 2 CO_2 C O 2 concentration at the very end of exhalation (normal: 35 − 45 mmHg 35 - 45 \text{ mmHg} 35 − 45 mmHg ).
Phase 0 Inspiratory Downstroke Rapid descent back to baseline ( 0 mmHg 0 \text{ mmHg} 0 mmHg ) as fresh, C O 2 CO_2 C O 2 -free gas is drawn into the circuit upon inspiration.
Arterial-to-End-Tidal C O 2 CO_2 C O 2 Gradient ( P a C O 2 − P E T C O 2 PaCO_2 - P_{ET}CO_2 P a C O 2 − P ET C O 2 )
In healthy individuals under general anesthesia, P a C O 2 PaCO_2 P a C O 2 exceeds P E T C O 2 P_{ET}CO_2 P ET C O 2 by 2 − 5 mmHg 2 - 5 \text{ mmHg} 2 − 5 mmHg due to normal physiological alveolar dead space ( V / Q > 1 V/Q > 1 V / Q > 1 ).
Factors that Widen the Gradient ( P a C O 2 ≫ P E T C O 2 PaCO_2 \gg P_{ET}CO_2 P a C O 2 ≫ P ET C O 2 ):
Increased alveolar dead space (pulmonary embolism, hypovolemia, excessive PEEP, upright/sitting position).
Decreased cardiac output or low pulmonary blood flow.
Chronic obstructive pulmonary disease (COPD) with severe V / Q V/Q V / Q mismatch.
4. Diagnostic Angles & Capnogram Waveform Pathologies +-------------------------------------------------------------------------+
- | CAPNOGRAPHY DIAGNOSTIC ANGLES |
- +-------------------+--------------------+--------------------------------+
- | Angle | Normal Value | Diagnostic Elevation Pathology |
- +-------------------+--------------------+--------------------------------+
- | **Alpha (α)** | 100° to 110° | Bronchospasm, COPD, kinked ETT |
- | (Between II & III)| | (Expiratory airflow resistance)|
- | **Beta (β)** | ~90° (Right angle) | Rebreathing of CO₂, incompetent|
- | (Between III & 0) | | expiratory valve, exhausted lime|
+-------------------+--------------------+--------------------------------+ 1. Bronchospasm ("Shark Fin") 2. Curare Cleft (Muscle Relaxant Wearing Off)
- /------------------D /----------\_/-------D
- / /
- / (Alpha Angle > 110°) / (Diaphragmatic effort notch)
- / /
- ---+ ----+
- 3. CO₂ Rebreathing / Valve Incompetence 4. Cardiac Oscillations
- /----------------D /--v--v--v--v----D
- / /
- / (Beta Angle > 90°) / (Pulsating heart recoil)
- _ / /
- \--+ (Elevated Phase I Baseline > 0) ----+
- Classic Capnography Pathologies & NCE Board Recognition
Obstructive Airflow / Shark-Fin Pattern:
Morphology: Prolonged, sluggish Phase II upstroke, steeply ascending Phase III slope, and an abnormally widened Alpha angle ( > 110 ∘ >110^\circ > 11 0 ∘ ) .
Etiologies: Bronchospasm (asthma), COPD, partially obstructed/kinked endotracheal tube, foreign body, or secretions in the airway adapter.
Curare Cleft:
Morphology: A discrete downward notch or dip appearing in the middle-to-late portion of the Phase III alveolar plateau.
Etiology: Patient attempting spontaneous breathing against the mechanical ventilator; uncoordinated diaphragmatic contraction draws C O 2 CO_2 C O 2 -free fresh gas across the sensor.
Action: Deepen anesthesia or administer additional neuromuscular blocking agent.
Cardiac Oscillations:
Morphology: Small, regular, rhythmic undulating ripples on the terminal Phase III plateau and Phase 0 downstroke.
Etiology: Mechanical pulsation of the contracting heart against adjacent left lower lobe pulmonary parenchyma in relaxed, thin patients with low respiratory rates.
C O 2 CO_2 C O 2 Rebreathing (Elevated Baseline):
Morphology: Phase I baseline fails to return to zero (elevated baseline > 0 mmHg >0 \text{ mmHg} > 0 mmHg ) and the Beta angle increases ( > 90 ∘ >90^\circ > 9 0 ∘ ) .
Etiologies: Incompetent expiratory unidirectional valve in the circle system, exhausted soda lime / carbon dioxide absorbent, or insufficient fresh gas flow in non-rebreathing Mapleson systems.
Esophageal Intubation:
Morphology: Small, transient C O 2 CO_2 C O 2 waveforms during the first 1 − 3 1 - 3 1 − 3 mechanical breaths (residual stomach gas from bag-mask ventilation) that rapidly decay to zero within 4 − 6 4 - 6 4 − 6 breaths, followed by a flatline.
Sudden Loss of E T C O 2 ETCO_2 ETC O 2 to Zero:
Etiologies: Circuit disconnection, accidental tracheal extubation, complete airway obstruction/plug, ventilator power failure, or cardiac arrest.
Sudden Exponential Plunge in E T C O 2 ETCO_2 ETC O 2 (without reaching zero):
Etiologies: Massive pulmonary thromboembolism, acute air embolism, profound acute systemic hypotension, or severe acute hemorrhage (loss of pulmonary capillary perfusion creating massive alveolar dead space).
5. Temperature Regulation & Core vs. Peripheral Sites
Under general and neuraxial anesthesia, behavioral thermoregulation is abolished and physiological thermoregulatory thresholds are profoundly blunted (interthreshold range widens from normal ± 0.2 ∘ C \pm 0.2^\circ\text{C} ± 0. 2 ∘ C to ≈ ± 2.0 − 4.0 ∘ C \approx \pm 2.0 - 4.0^\circ\text{C} ≈ ± 2.0 − 4. 0 ∘ C ). +-------------------------------------------------------------------------+
- | TEMPERATURE MONITORING SITES |
- +------------------------------------+------------------------------------+
- | Core Temperature Sites | Intermediate & Peripheral Sites |
- | (Rapid response, high accuracy) | (Subject to thermal lag/errors) |
- +------------------------------------+------------------------------------+
- | 1. Distal Esophagus (Lower 1/3) | 1. Urinary Bladder (accurate only |
- | - Placed retrocardiac in lower | with high urine output) |
- | fourth of esophagus | 2. Rectum (slow response; fecal lag|
- | 2. Tympanic Membrane (Thermocouple)| 3. Axilla (reflects skin/periphery)|
- | - Direct contact with membrane | 4. Forehead Liquid Crystal Skin |
- | 3. Pulmonary Artery Catheter | - Correlates poorly with core |
- | - Gold standard core reference | temperature during rapid drops|
- | 4. Nasopharynx (Posterior wall) | |
- | - Reflects brain core temp | |
- +------------------------------------+------------------------------------+
NCE Clinical Pearl — Distal Esophageal Probe Placement: To record true core body temperature without false cooling from cold inhaled respiratory gases, the esophageal temperature probe must be positioned in the distal third (lower fourth) of the esophagus , where it sits directly posterior to the left atrium. Placement depth is approximately 38 − 42 cm 38 - 42 \text{ cm} 38 − 42 cm from the incisors in an adult, confirmed at the point of maximal heart sounds on an esophageal stethoscope.
6. Perioperative Hypothermia: Phases, Mechanisms & Clinical Sequelae
Perioperative hypothermia is defined as a core body temperature < 36.0 ∘ C <36.0^\circ\text{C} < 36. 0 ∘ C ( < 96.8 ∘ F <96.8^\circ\text{F} < 96. 8 ∘ F ) . Anesthetic drugs induce peripheral vasodilation and suppress hypothalamic vasoconstriction thresholds. +-------------------------------------------------------------------------+
- | THREE PHASES OF PERIOPERATIVE HYPOTHERMIA |
- +-------------------------------------------------------------------------+
- | |
- | Phase 1: Internal Redistribution Hypothermia (Hour 1) |
- | • Core temp drops precipitously by 1.0°C to 1.5°C |
- | • Anesthesia-induced vasodilation allows warm core blood to flow to |
- | cooler peripheral tissues (responsible for >80% of initial drop) |
- | |
- | Phase 2: Linear Heat Loss (Hours 2 to 3) |
- | • Slower, steady, linear temperature decline |
- | • Environmental heat loss (radiation, convection) exceeds metabolic |
- | heat production |
- | |
- | Phase 3: Thermal Plateau (Hours 3 to 4+) |
- | • Core temperature stabilizes |
- | • Metabolic heat production reaches equilibrium with heat loss, or |
- | anesthetic-blunted peripheral vasoconstriction finally triggers |
- +-------------------------------------------------------------------------+
- Mechanisms of Operating Room Heat Loss
Heat Loss Mechanism Proportion of Total Loss Physical Principle & Prevention
Radiation 40 − 60 % 40 - 60\% 40 − 60% (PRIMARY) Infrared thermal electromagnetic radiation emitted from warm body surfaces to colder OR walls. Minimized by forced-air warming blankets and reflective thermal drapes.
Convection 25 − 30 % 25 - 30\% 25 − 30% (SECOND) Moving cold laminar air currents stripping heat away from exposed skin. Minimized by covering exposed limbs and minimizing room air velocity.
Evaporation 10 − 20 % 10 - 20\% 10 − 20% Latent heat of vaporization from wet skin prep solutions, exposed peritoneal viscera, and unhumidified dry breathing gases. Minimized by low fresh gas flows and active circuit humidifiers.
Conduction < 5 % <5\% < 5% Direct transfer of heat to cold OR tables and unheated intravenous fluids. 1 Liter of room-temperature fluid drops core temp by ≈ 0.25 ∘ C \approx 0.25^\circ\text{C} ≈ 0.2 5 ∘ C ; 1 unit refrigerated blood drops core temp by ≈ 0.5 ∘ C \approx 0.5^\circ\text{C} ≈ 0. 5 ∘ C .
Adverse Consequences of Perioperative Hypothermia
Post-Anesthetic Shivering & Oxygen Consumption Surge: Involuntary uncoordinated thermogenic muscle contractions increase total metabolic rate and oxygen consumption ( V O 2 VO_2 V O 2 ) by up to 400 % 400\% 400% (4-fold) . In patients with coronary artery disease, this metabolic surge triggers subendocardial ischemia, lactic acidosis, and hypoxemia.
Treatment: Meperidine (Demerol) 12.5 − 25 mg 12.5 - 25 \text{ mg} 12.5 − 25 mg IV (acts via κ \kappa κ -opioid receptor stimulation to lower shivering threshold), dexmedetomidine, or clonidine.
Coagulopathy & Increased Hemorrhage: Lowers platelet activation/aggregation and inhibits the enzymatic activity of the coagulation cascade. Every 1.0 ∘ C 1.0^\circ\text{C} 1. 0 ∘ C drop in core temperature increases surgical blood loss by ≈ 15 − 20 % \approx 15 - 20\% ≈ 15 − 20% .
NCE Diagnostic Trap: Laboratory coagulation studies (PT/INR, aPTT) are routinely warmed to 37 ∘ C 37^\circ\text{C} 3 7 ∘ C in the hospital laboratory, falsely masking in vivo hypothermic coagulopathy!
Delayed Drug Clearance & Emergence: Hepatic clearance of opioids, volatile anesthetics, and neuromuscular blockers is severely reduced. Minimum Alveolar Concentration (MAC) of volatile anesthetics decreases by ≈ 5 % \approx 5\% ≈ 5% for every 1.0 ∘ C 1.0^\circ\text{C} 1. 0 ∘ C decrease in core temperature.
Surgical Site Infections (SSI): Hypothermia-induced vasoconstriction impairs tissue perfusion and subcutaneous oxygen delivery, suppressing neutrophil oxidative killing and increasing wound infection rates 3-fold.